FMC Bozeman is a medicare approved dialysis facility center in Bozeman, Montana and it has 8 dialysis stations. It is located in Gallatin county at 936 Highland Blvd #5100, Bozeman, MT, 59715. You can reach out to the office of FMC Bozeman at (406) 585-5090. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Bozeman has the following ownership type - Profit. It was first certified by medicare in March, 1998. The medicare id for this facility is 272503 and it accepts patients under medicare ESRD program.
| Name | FMC Bozeman |
|---|---|
| Location | 936 Highland Blvd #5100, Bozeman, Montana |
| No. of Dialysis Stations | 8 |
| Medicare ID | 272503 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 936 Highland Blvd #5100, Bozeman, Montana, 59715 | |
| (406) 585-5090 | |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
| NPI Number | 1083999601 |
| Organization Name | Fresenius Medical Care Bozeman |
| Doing Business As | Fresenius Medical Care Of Montana, Llc |
| Address | 931 Highland Blvd Bozeman, Montana, 59715 |
| Phone Number | (406) 585-5090 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
| NPI Number | 1700942455 |
| Doing Business As | Bozeman Dialysis Center |
| Address | 931 Highland Blvd Bozeman, Montana, 59715 |
| Phone Number | (406) 585-5090 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 18 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 11 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 42 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 357 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
| Adult patients getting regular peritoneal dialysis at the center | 11 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 92 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 96 |
| Pediatric patients getting regular peritoneal dialysis at the centre | 1 |
| Pediatric patient months included in Kt/V greater than or equal to 1.7 | 2 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Bozeman with elevated calcium levels.
| Patients with hypercalcemia | 51 |
| Hypercalcemia patient months | 460 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 56 |
| Patients with Serumphosphor less than 3.5 mg/dL | 6 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 21 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 31 |
| Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 45 |
| Patient months included in arterial venous fistula and catheter summaries | 288 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 72 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 9 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 40 |
| Hospitalization Rate in facility | 150.5 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 299 |
| Hospitalization Rate: Lower Confidence Limit | 79.4 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC Bozeman were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 33.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 44.6 |
| Readmission Rate: Lower Confidence Limit | 22.9 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC Bozeman get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .27 (As Expected) |
| SIR: Upper Confidence Limit | 1.33 |
| SIR: Lower Confidence Limit | .01 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC Bozeman's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 31 |
| Transfusion Rate in facility | 5.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 198.1 |
| Transfusion Rate: Lower Confidence Limit | .3 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC Bozeman lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 186 |
| Mortality Rate in facility | 22.2 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 31.2 |
| Mortality Rate: Lower Confidence Limit | 15.3 |
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago
News Archive
A 2.3m euros project to tackle the escalating problem of frailty among Europe's ageing population will be conducted by an international team of researchers.
Egalet Corporation today reported financial results for the year ended December 31, 2014.
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumors of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable.
SQI Diagnostics Inc., a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the first quarter-ended December 31, 2012.
Tufts University today announced the public launch of the Tufts Institute for Biomedical Partnerships website/HUB: www.tuftspharmapartners.org.
› Verified 1 days ago